ID
31488
Description
Study ID: 104619 Clinical Study ID: 63129 Study Title:A multinational, randomized, double-blind comparison of once daily subcutaneous fondaparinux sodium with placebo for the prevention of venous thromboembolic events in acutely ill medical patients (ARTEMIS). Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 3 Study Recruitment Status: Completed Generic Name: fondaparinux sodium Trade Name: Arixtra Study Indication: Thrombosis, Venous
Keywords
Versions (1)
- 8/28/18 8/28/18 -
Copyright Holder
GlaxoSmithKline
Uploaded on
August 28, 2018
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Subcutaneous fondaparinux sodium for prevention of venous thromboembolic events; Study ID: 104619
End of Treatment/End of Study
- StudyEvent: ODM
Description
End of Study
Alias
- UMLS CUI-1
- C0008972
- UMLS CUI-2
- C0444930
Description
Study end Date
Data type
date
Alias
- UMLS CUI [1]
- C2983670
Description
Clinical Research, end; Reason
Data type
text
Alias
- UMLS CUI [1,1]
- C0008972
- UMLS CUI [1,2]
- C0444930
- UMLS CUI [1,3]
- C0566251
Description
Clinical Research; study code
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0008972
- UMLS CUI [1,2]
- C0805701
Similar models
End of Treatment/End of Study
- StudyEvent: ODM
C1762893 (UMLS CUI [1,2])
C0444930 (UMLS CUI [1,2])
C0566251 (UMLS CUI [1,3])
C0444930 (UMLS CUI [1,2])
C0566251 (UMLS CUI [1,3])
C0805701 (UMLS CUI [1,2])